GC
Gratus Capital Portfolio holdings
AUM
$2.48B
1-Year Return
32.66%
This Quarter Return
+7.56%
1 Year Return
+32.66%
3 Year Return
+50.91%
5 Year Return
+137.89%
10 Year Return
–
AUM
$639M
AUM Growth
+$51.4M
(+8.8%)
Cap. Flow
+$15.5M
Cap. Flow
% of AUM
2.43%
Top 10 Holdings %
Top 10 Hldgs %
24.26%
Holding
179
New
20
Increased
38
Reduced
76
Closed
13
Top Buys
| 1 |
iShares Core Dividend Growth ETF
DGRO
|
$19.7M |
| 2 |
Invesco Ultra Short Duration ETF
GSY
|
$13.9M |
| 3 |
iShares International Dividend Growth ETF
IGRO
|
$13.4M |
| 4 |
VF Corp
VFC
|
$8.35M |
| 5 |
IQVIA
IQV
|
$6.73M |
Top Sells
| 1 |
Schwab US Large- Cap ETF
SCHX
|
$16.5M |
| 2 |
Schwab International Equity ETF
SCHF
|
$11.9M |
| 3 |
Amazon
AMZN
|
$9.47M |
| 4 |
Baxter International
BAX
|
$7.4M |
| 5 |
Phillips 66
PSX
|
$7.09M |
Sector Composition
| 1 | Technology | 16.71% |
| 2 | Healthcare | 11.9% |
| 3 | Financials | 9.82% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bristol-Myers Squibb
BMY
$96B
| $439K | 0.07% |
7,279
-1,725
| -19% | -$104K |
|
127
Stepan Co
SCL
$1.13B
| $435K | 0.07% |
3,992
+780
| +24% | +$85K |
|
128
Philip Morris
PM
$251B
| $425K | 0.07% |
5,673
+2
| +0% | +$150 |
|
129
Fulgent Genetics
FLGT
$672M
| $400K | 0.06% |
10,000
| – | – |
|
130
Acuity Brands
AYI
$10.4B
| $386K | 0.06% |
3,773
| – | – |
|
131
Altria Group
MO
$112B
| $375K | 0.06% |
9,718
-1,504
| -13% | -$58K |
|
132
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
| $361K | 0.06% |
+4,180
| New | +$361K |
|
133
Kodiak Sciences
KOD
$556M
| $355K | 0.06% |
+6,000
| New | +$355K |
|
134
AT&T
T
$212B
| $353K | 0.06% |
16,411
+363
| +2% | +$7.81K |
|
135
Cognizant
CTSH
$35.1B
| $347K | 0.05% |
5,000
| – | – |
|
136
Southern Company
SO
$101B
| $326K | 0.05% |
6,017
+6
| +0.1% | +$325 |
|
|
CERN
137
DELISTED
Cerner Corp
CERN
| $318K | 0.05% |
4,404
-189
| -4% | -$13.6K |
|
138
Starbucks
SBUX
$97.1B
| $310K | 0.05% |
3,612
+43
| +1% | +$3.69K |
|
139
W.R. Berkley
WRB
$27.3B
| $302K | 0.05% |
+11,124
| New | +$302K |
|
140
Biogen
BIIB
$20.6B
| $298K | 0.05% |
1,050
| – | – |
|
141
Bank of America
BAC
$369B
| $297K | 0.05% |
12,335
-4,849
| -28% | -$117K |
|
142
Danaher
DHR
$143B
| $292K | 0.05% |
1,531
| – | – |
|
143
iShares Russell Top 200 Growth ETF
IWY
$14.9B
| $289K | 0.05% |
+2,384
| New | +$289K |
|
144
Martin Marietta Materials
MLM
$37.5B
| $289K | 0.05% |
1,230
| – | – |
|
|
ISEE
145
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $282K | 0.04% |
50,000
| – | – |
|
146
Pan American Silver
PAAS
$14.6B
| $280K | 0.04% |
8,700
| – | – |
|
147
Meta Platforms (Facebook)
META
$1.89T
| $262K | 0.04% |
1,000
-100
| -9% | -$26.2K |
|
148
Vanguard Dividend Appreciation ETF
VIG
$95.8B
| $259K | 0.04% |
2,017
-39,536
| -95% | -$5.08M |
|
149
GSK
GSK
$81.5B
| $258K | 0.04% |
5,478
-1,749
| -24% | -$82.4K |
|
150
FMC
FMC
$4.72B
| $254K | 0.04% |
2,400
| – | – |
|